Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
L-ISOLEUCINE; L-LEUCINE; L-LYSINE (L-LYSINE ACETATE); METHIONINE; L-PHENYLALANINE; L-THREONINE; TRYPTOPHAN; L-VALINE; L-ALANINE; L-ARGININE; L-ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; L-PROLINE; SERINE; N-ACETYL-L-TYROSINE
ICU MEDICAL CANADA INC
B05BA01
AMINO ACIDS
660MG; 1000MG; 1050MG; 172MG; 298MG; 400MG; 200MG; 500MG; 993MG; 1018MG; 700MG; 738MG; 500MG; 300MG; 722MG; 530MG; 270MG
SOLUTION
L-ISOLEUCINE 660MG; L-LEUCINE 1000MG; L-LYSINE (L-LYSINE ACETATE) 1050MG; METHIONINE 172MG; L-PHENYLALANINE 298MG; L-THREONINE 400MG; TRYPTOPHAN 200MG; L-VALINE 500MG; L-ALANINE 993MG; L-ARGININE 1018MG; L-ASPARTIC ACID 700MG; GLUTAMIC ACID 738MG; GLYCINE 500MG; HISTIDINE 300MG; L-PROLINE 722MG; SERINE 530MG; N-ACETYL-L-TYROSINE 270MG
INTRAVENOUS
1000ML/2000ML
Ethical
CALORIC AGENTS
Active ingredient group (AIG) number: 1750888002; AHFS:
APPROVED
2004-06-08
PRESCRIBING INFORMATION AMINOSYN TM II (amino acids for injection 10% and 15% w/v) SULFITE-FREE NUTRITIVE SUPPLEMENT FOR INTRAVENOUS INFUSION ICU Medical Canada Inc. DATE OF PREPARATION: 2600 boul. Alfred-Nobel, suite 100 December 21, 2017 St-Laurent, Quebec H4S 0A9 Control # 210235 _PRESCRIBING INFORMATION; Aminosyn_ _TM_ _ II _ _ _ _Page 2 of 16 _ PRESCRIBING INFORMATION NAME OF DRUGS AMINOSYN TM II (amino acids for injection 10% and 15% w/v) Sulfite-Free THERAPEUTIC OR PHARMACOLOGICAL CLASSIFICATION Nutritive Supplement for Intravenous Infusion ACTIONS AND CLINICAL PHARMACOLOGY AMINOSYN II (amino acids for injection 10% and 15%) provides crystalline amino acids which, when administered with appropriate source of energy, promote protein synthesis and wound healing and prevent endogenous protein catabolism. AMINOSYN II, when given by peripheral or central venous infusion in combination with dextrose, electrolytes, vitamins, trace metals and/or ancillary fat supplements, constitutes Total Parenteral Nutrition (TPN). INDICATIONS AND CLINICAL USE Parenteral nutrition with AMINOSYN II 10% and 15% is indicated to prevent nitrogen loss or treat negative nitrogen balance in adults and children where: 1. the alimentary tract, by the oral, gastrotomy, or jejunostomy route cannot or should not be used, or adequate protein intake is not feasible by these routes; 2. gastrointestinal absorption of protein is impaired; or 3. protein requirements are substantially increased as with extensive burns. Dosage, route of administration, and concomitant infusion of non-protein calories are dependent on various factors, such as nutritional and metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance. (See DOSAGE AND ADMINISTRATION for additional information). _PRESCRIBING INFORMATION; Aminosyn_ _TM_ _ II _ _ _ _Page 3 of 16 _ CONTRAINDICATIONS AMINOSYN II is contraindicated in patients with previous hypersensitivity to this product or any of its components. These preparations should n Soma hati kamili